OVARIAN CANCER SCREENING STUDY

卵巢癌筛查研究

基本信息

  • 批准号:
    7604949
  • 负责人:
  • 金额:
    $ 2.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-03-01 至 2008-02-29
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study aims to determine the efficacy of CA 125 as a screening tool for detecting early stage ovarian cancer in women at high risk. Women have been recruited based on family and personal history of cancer and BRCA1 or BRCA2 mutation status. A blood draw is done and CA 125 levels are measured every three to six months. Each CA 125 result is evaluated with a computer algorithm to generate an individual specific risk level of developing ovarian cancer. Women determined to be at higher risk are offered trans-vaginal sonography to evaluate their ovaries. As warranted, based on the ultrasound results, women may meet with a gynecological oncologist for personalized management. Enrolled women who have ovaries were originally followed every three months, but the protocol has since changed and the women are being follow-up every six months until the end of the study. Women who have their ovaries removed during the course of the study are asked to participate in one final follow-up to compare a current CA 125 level with previous levels. A separate form is signed by these women to indicate their intent to remain in the study and participate in the final follow-up.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAUNDRA S BUYS其他文献

SAUNDRA S BUYS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAUNDRA S BUYS', 18)}}的其他基金

Leveraging an electronic medical record infrastructure to identify primary care patients eligible for genetic testing for hereditary cancer and evaluate novel cancer genetics service delivery models
利用电子病历基础设施来识别有资格接受遗传性癌症基因检测的初级保健患者,并评估新型癌症遗传学服务提供模式
  • 批准号:
    9788088
  • 财政年份:
    2018
  • 资助金额:
    $ 2.25万
  • 项目类别:
HIGH RISK BREAST CANCER CLINIC
高风险乳腺癌诊所
  • 批准号:
    7718530
  • 财政年份:
    2008
  • 资助金额:
    $ 2.25万
  • 项目类别:
OVARIAN CANCER SCREENING STUDY
卵巢癌筛查研究
  • 批准号:
    7718491
  • 财政年份:
    2008
  • 资助金额:
    $ 2.25万
  • 项目类别:
HIGH RISK BREAST CANCER CLINIC
高风险乳腺癌诊所
  • 批准号:
    7604987
  • 财政年份:
    2007
  • 资助金额:
    $ 2.25万
  • 项目类别:
OVARIAN CANCER SCREENING STUDY
卵巢癌筛查研究
  • 批准号:
    7376468
  • 财政年份:
    2006
  • 资助金额:
    $ 2.25万
  • 项目类别:
PROSTATE, LUNG, COLORECTAL AND OVARIAN SCREENING TRIAL
前列腺、肺、结直肠和卵巢筛查试验
  • 批准号:
    7376459
  • 财政年份:
    2006
  • 资助金额:
    $ 2.25万
  • 项目类别:
HIGH RISK BREAST CANCER CLINIC
高风险乳腺癌诊所
  • 批准号:
    7376460
  • 财政年份:
    2006
  • 资助金额:
    $ 2.25万
  • 项目类别:
PROSTATE, LUNG, COLORECTAL AND OVARIAN SCREENING TRIAL
前列腺、肺、结直肠和卵巢筛查试验
  • 批准号:
    7201444
  • 财政年份:
    2005
  • 资助金额:
    $ 2.25万
  • 项目类别:
OVARIAN CANCER SCREENING STUDY
卵巢癌筛查研究
  • 批准号:
    7201459
  • 财政年份:
    2005
  • 资助金额:
    $ 2.25万
  • 项目类别:
HIGH RISK BREAST CANCER CLINIC
高风险乳腺癌诊所
  • 批准号:
    7201445
  • 财政年份:
    2005
  • 资助金额:
    $ 2.25万
  • 项目类别:

相似海外基金

Identification of critical regulatory elements in the BRCA1 gene
BRCA1 基因中关键调控元件的鉴定
  • 批准号:
    nhmrc : 143037
  • 财政年份:
    2001
  • 资助金额:
    $ 2.25万
  • 项目类别:
    NHMRC Project Grants
ROLE OF THE BRCA1 GENE IN SPORADIC CANCER
BRCA1 基因在散发性癌症中的作用
  • 批准号:
    6356510
  • 财政年份:
    2000
  • 资助金额:
    $ 2.25万
  • 项目类别:
ROLE OF THE BRCA1 GENE IN SPORADIC CANCER
BRCA1 基因在散发性癌症中的作用
  • 批准号:
    6664498
  • 财政年份:
    1999
  • 资助金额:
    $ 2.25万
  • 项目类别:
ROLE OF THE BRCA1 GENE IN SPORADIC CANCER
BRCA1 基因在散发性癌症中的作用
  • 批准号:
    6203339
  • 财政年份:
    1999
  • 资助金额:
    $ 2.25万
  • 项目类别:
BRCA1 GENE STRUCTURAL ALTERATIONS IN BREAST TUMORS
乳腺肿瘤中的 BRCA1 基因结构改变
  • 批准号:
    6173178
  • 财政年份:
    1998
  • 资助金额:
    $ 2.25万
  • 项目类别:
BRCA1 GENE STRUCTURAL ALTERATIONS IN BREAST TUMORS
乳腺肿瘤中的 BRCA1 基因结构改变
  • 批准号:
    2593383
  • 财政年份:
    1998
  • 资助金额:
    $ 2.25万
  • 项目类别:
BRCA1 GENE STRUCTURAL ALTERATIONS IN BREAST TUMORS
乳腺肿瘤中的 BRCA1 基因结构改变
  • 批准号:
    2896427
  • 财政年份:
    1998
  • 资助金额:
    $ 2.25万
  • 项目类别:
ROLE OF THE BRCA1 GENE IN SPORADIC CANCER
BRCA1 基因在散发性癌症中的作用
  • 批准号:
    6103135
  • 财政年份:
    1998
  • 资助金额:
    $ 2.25万
  • 项目类别:
ISOLATION AND MUTATION ANALYSIS OF THE BRCA1 GENE
BRCA1基因的分离及突变分析
  • 批准号:
    2111084
  • 财政年份:
    1996
  • 资助金额:
    $ 2.25万
  • 项目类别:
ISOLATION AND MUTATION ANALYSIS OF THE BRCA1 GENE
BRCA1基因的分离及突变分析
  • 批准号:
    2111083
  • 财政年份:
    1995
  • 资助金额:
    $ 2.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了